1. Home
  2. ZURA vs FPI Comparison

ZURA vs FPI Comparison

Compare ZURA & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$4.09

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

N/A

Current Price

$10.53

Market Cap

473.8M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
FPI
Founded
2022
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
473.8M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
ZURA
FPI
Price
$4.09
$10.53
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $18.00
N/A
AVG Volume (30 Days)
★ 1.8M
656.9K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
★ 3.43%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.08
Revenue
N/A
★ $52,178,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$131.13
Revenue Growth
★ N/A
N/A
52 Week Low
$3.15
$9.21
52 Week High
$7.25
$13.23

Technical Indicators

Market Signals
Indicator
ZURA
FPI
Relative Strength Index (RSI) 36.17 44.39
Support Level $3.90 $10.13
Resistance Level $5.87 $10.62
Average True Range (ATR) 0.29 0.30
MACD 0.03 -0.10
Stochastic Oscillator 34.37 21.37

Price Performance

Historical Comparison
ZURA
FPI

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: